实验动物与比较医学 ›› 2016, Vol. 36 ›› Issue (6): 466-472.DOI: 10.3969/j.issn.1674-5817.2016.06.013
李冬冬, 朱敏, 庞琴霞, 丁佩芳
收稿日期:
2016-08-08
出版日期:
2016-12-25
发布日期:
2016-12-25
作者简介:
李冬冬(1987-), 女, 硕士, 研究方向: 子宫肌瘤发病机制及治疗。E-mail: best_ldd@sina.com
基金资助:
LI Dong-dong, ZHU Min, PANG Qin-xia, Ding Pei-fang
Received:
2016-08-08
Online:
2016-12-25
Published:
2016-12-25
摘要: 先兆子痫(PE)是以高血压、蛋白尿、水肿为主要临床特征的妇产科疾病,并常伴有全身 多个脏器损害, 是严重威胁母婴安全、导致孕、产妇及围生儿发病及死亡的重要原因,其病因及 发病机制至今尚未完全明确。借助PE动物模型开展相关研究,是阐明该疾病的发病机制或药物 疗效的重要手段。目前,该疾病的造模方法主要分为环境刺激法、化学药物干扰法、手术干预法、 基因干预法四类。所选择的动物主要有大鼠、小鼠。此外,家兔、犬、猕猴、狒狒、羊等在手术 干预法中也有应用。在PE发病机制的研究中,动物模型起着重要作用,本文对PE动物模型制备 方法进行综述,并进一步介绍了各种方法制备的动物模型的评价标准及其特点。
中图分类号:
李冬冬, 朱敏, 庞琴霞, 丁佩芳. 先兆子痫动物模型的制备[J]. 实验动物与比较医学, 2016, 36(6): 466-472.
LI Dong-dong, ZHU Min, PANG Qin-xia, Ding Pei-fang. Preparation of Pre-eclampsia Animal Model[J]. Laboratory Animal and Comparative Medicine, 2016, 36(6): 466-472.
[1] Mustafa R, Ahmed S, Gupta A, et al.A comprehensive review of hypertension in pregnancy[J]. J Pregnancy, 2012, 2012: 105918. [2] Garovic VD, August P.Preeclampsia and the future risk of hypertension: the pregnant evidence[J]. Curr Hypertens Rep, 2013, 15(2):114-121. [3] 刘翔, 任红旗. 先兆子痫肾损害发病机制的研究进展[J]. 中华临床医师杂志(电子版), 2015(13):2577-2582. [4] Das UN.Cytokines, angiogenic, and antiangiogenic factors and bioactive lipids in preeclampsia[J]. Nutrition, 2015, 31(9): 1083-1095. [5] Falcao S, Bisotto S, Gutkowska J, et al. Hyperhomocysteinemia is not sufficient to cause preeclampsia in an animal model: the importance of folate intake[J]. Am J Obstet Gynecol, 2009, 200(2):198.e1-5. [6] Kasawara KT, Surita FG, Pinto ESJL.Translational studies for exercise in high-risk pregnancy: Pre-eclampsia model[J]. Hypertens Pregnancy, 2016, 35(3):265-279. [7] Kanayama N, Tsujimura R, She L, et al.Cold-induced stress stimulates the sympathetic nervous system, causing hypertension and proteinuria in rats[J]. J Hypertens, 1997, 15(4): 383-389. [8] 俞丽丽, 李力, 陈鸣, 等. 寒冷刺激诱发孕鼠妊娠高血压综合征动物模型研究[J]. 第三军医大学学报, 2001, 23(4): 419-421. [9] 刘远芳, 张红. 黄芪皂苷甲对妊娠高血压大鼠模型的治疗作用及其对胎盘中血管内皮生长因子表达的影响[J]. 中国妇幼保健, 2013, 28(26):4361-4362. [10] Faas MM, Schuiling GA, Baller JF, et al.A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats[J]. Am J Obstet Gynecol, 1994, 171(1): 158-164. [11] Wang LL, Yu Y, Guan HB, et al.Effect of human umbilical cord mesenchymal stem cell transplantation in a rat model of preeclampsia[J]. Reprod Sci, 2016, 23(8):1058-1070. [12] Hu BH, Yang JY, Huang Q, et al.Cyclosporin A significantly improves preeclampsia signs and suppresses inflammation in a rat model[J]. Cytokine, 2016, 81:77-81. [13] Fu L, Liu Y, Zhang D, et al.Beneficial effect of human umbilical cord-derived mesenchymal stem cells on an endotoxin-induced rat model of preeclampsia[J]. Exp Ther Med, 2015, 10(5):1851-1856. [14] 王志坚, 余艳红. 抗细胞间黏附分子-1单克隆抗体对大鼠子痫前期的治疗作用[J]. 现代妇产科进展, 2007, 16(9): 661-663. [15] Hawfield A, Freedman BI.Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detection[J]. Ther Adv Cardiovasc Dis, 2009, 3(1):65-73. [16] Faas MM, Broekema M, Moes H, et al.Altered monocyte function in experimental preeclampsia in the rat[J]. Am J Obstet Gynecol, 2004, 191(4):1192-1198. [17] 王忠民, 王波, 叶萍, 等. 精氨酸对大鼠妊娠高征的治疗作用及其机制的探讨[J]. 上海实验动物科学, 2003, 23(3): 148-150. [18] Alexander BT, Llinas MT, Kruckeberg WC, et al.L-arginine attenuates hypertension in pregnant rats with reduced uterine perfusion pressure[J]. Hypertension, 2004, 43(4):832-836. [19] 金娅, 孙成娟, 张为远. AKR1C3对子痫前期大鼠肾损伤的影响[J]. 中华医学杂志, 2015, 95(1):30-33. [20] Shi X, Chen P, Liu H, et al.Decitabine improves the clinical manifestations of rats with l-NAME-induced pre-eclampsia: a potential approach to studying pre-eclampsia[J]. Hypertens Pregnancy, 2015, 34(4):464-473. [21] 卢敏, 龚护民, 施蕾, 等. 大鼠子痫前期动物模型的建立[J]. 海南医学, 2012, 23(16):21-23. [22] Li H, Ohta H, Tahara Y, et al.Artificial oxygen carriers rescue placental hypoxia and improve fetal development in the rat pre-eclampsia model[J]. Sci Rep, 2015, 5:15271. [23] Liu Q, Yang J.Expression and significance of miR155 and vascular endothelial growth factor in placenta of rats with preeclampsia[J]. Int J Clin Exp Med, 2015, 8(9):15731-15737. [24] Jiang Z, Zou Y, Ge Z, et al.A role of sFlt-1 in oxidative stress and apoptosis in human and mouse pre-eclamptic trophoblasts[J]. Biol Reprod, 2015, 93(3):73. [25] Bridges JP, Gilbert JS, Colson D, et al.Oxidative stress contributes to soluble fms-like tyrosine kinase-1 induced vascular dysfunction in pregnant rats[J]. Am J Hypertens, 2009, 22(5):564-568. [26] Grujic I, Milasinovic L.Hypertension, pre-eclampsia and eclampsia-monitoring and outcome of pregnancy[J]. Med Pregl, 2006, 59(11-12):556-559. [27] Neerhof MG, Synowiec S, Khan S, et al.Impact of endothelin A receptor antagonist selectivity in chronic nitric oxide synthase inhibition-induced fetal growth restriction in the rat[J]. Hypertens Pregnancy, 2010, 29(3):284-293. [28] Pedrycz A, Wieczorski M, Czerny K.Secondary preeclampsia in rats with nephrotic syndrome-experimental model[J]. Reprod Toxicol, 2005, 19(4):493-500. [29] Yousif MH, Adeagbo AS, Kadavil EA, et al.Acetylcholine-induced vasodilation in the uterine vascular bed of pregnant rats with adriamycin-induced nephrosis[J]. Med Princ Pract, 2002, 11(2):57-64. [30] Podjarny E, Losonczy G, Baylis C.Animal models of preeclampsia[J]. Semin Nephrol, 2004, 24(6):596-606. [31] Podjarny E, Baylis C, Losonczy G.Animal models of preeclampsia[J]. Semin Perinatol, 1999, 23(1):2-13. [32] Omatsu K, Kobayashi T, Murakami Y, et al.Phosphatidylserine/phosphatidylcholine microvesicles can induce preeclampsia-like changes in pregnant mice[J]. Semin Thromb Hemost, 2005, 31(3):314-320. [33] 郝莎, 李鹏飞, 李若天, 等. 子痫前期小鼠动物模型的NK细胞和细胞因子的变化[J]. 中国免疫学杂志, 2009, 25(8): 708-712. [34] 张焱, 胡娅莉, 孟奎, 等. 胎盘广泛性微血栓在子痫前期发病中的作用一种新的子痫前期动物模型评价[J]. 现代妇产科进展, 2007, 16(9):679-683. [35] 张焱, 胡娅莉, 华子春, 等. 肝素钠和低分子肝素钙对子痫前期模型小鼠抗凝治疗的效果[J]. 中华围产医学杂志, 2015, 18(2):123-126. [36] Dai SJ, Liang DD, Ren Y, et al.New neo-clerodane diterpenoid alkaloids from Scutellaria barbata with cytotoxic activities[J]. Chem Pharm Bull (Tokyo), 2008, 56(2):207-209. [37] Dai SJ, Peng WB, Shen L, et al.Two new neo-clerodane diterpenoid alkaloids from Scutellaria barbata with cytotoxic activities[J]. J Asian Nat Prod Res, 2009, 11(5):451-456. [38] 徐鑫, 杨星宇, 何碧薇, 等. TLR9激动剂诱导建立小鼠子痫前期动物模型的研究[J]. 现代妇产科进展, 2015, 24(4): 266-272. [39] Gadonski G, LaMarca BB, Sullivan E, et al. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6[J]. Hypertension, 2006, 48(4):711-716. [40] Lamarca B, Speed J, Ray LF, et al.Hypertension in response to IL-6 during pregnancy: role of AT1-receptor activation[J]. Int J Interferon Cytokine Mediat Res, 2011, 2011(3): 65-70. [41] Gilbert JS, Ryan MJ, LaMarca BB, et al. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction[J]. Am J Physiol Heart Circ Physiol, 2008, 294(2):H541-550. [42] LaMarca BB, Bennett WA, Alexander BT, et al. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha[J]. Hypertension, 2005, 46(4):1022-1025. [43] LaMarca B, Wallukat G, Llinas M, et al. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats[J]. Hypertension, 2008, 52(6):1168-1172. [44] Bobek G, Surmon L, Mirabito KM, et al.Placental Regulation of Inflammation and Hypoxia after TNF-alpha Infusion in Mice[J]. Am J Reprod Immunol, 2015, 74(5):407-418. [45] Conrad KP, Benyo DF.Placental cytokines and the pathogenesis of preeclampsia[J]. Am J Reprod Immunol, 1997, 37(3): 240-249. [46] Benyo DF, Smarason A, Redman CW, et al.Expression of inflammatory cytokines in placentas from women with preeclampsia[J]. J Clin Endocrinol Metab, 2001, 86(6):2505-2512. [47] Xia Y, Ramin SM, Kellems RE.Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia[J]. Hypertension, 2007, 50(2):269-275. [48] Dechend R, Homuth V, Wallukat G, et al.Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia[J]. J Soc Gynecol Investig, 2006, 13(2):79-86. [49] Dhillion P, Wallace K, Herse F, et al.IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy[J]. Am J Physiol Regul Integr Comp Physiol, 2012, 303(4):R353-358. [50] Winship AL, Koga K, Menkhorst E, et al.Interleukin-11 alters placentation and causes preeclampsia features in mice[J]. Proc Natl Acad Sci U S A, 2015, 112(52):15928-15933. [51] Lim R, Adhikari S, Gurusinghe S, et al.Inhibition of activin A signalling in a mouse model of pre-eclampsia[J]. Placenta, 2015, 36(8):926-931. [52] Zhang D, Liu H, Zeng J, et al.Glucocorticoid exposure in early placentation induces preeclampsia in rats via interfering trophoblast development[J]. Gen Comp Endocrinol, 2016, 225: 61-70. [53] Laszlo KD, Liu XQ, Svensson T, et al.Psychosocial stress related to the loss of a close relative the year before or during pregnancy and risk of preeclampsia[J]. Hypertension, 2013, 62(1):183-189. [54] Ogden E, Hildebrand GJ, Page EW.Rise of blood pressure during ischemia of the gravid uterus[J]. Exp Biol Med, 1940, 43:49-51. [55] Hodari AA.Chronic uterine ischemia and reversible experimental "toxemia of pregnancy"[J]. Am J Obstet Gynecol, 1967, 97(5):597-607. [56] Abitbol MM, Pirani CL, Ober WB, et al.Production of experimental toxemia in the pregnant dog[J]. Obstet Gynecol, 1976, 48(5):537-548. [57] Losonczy G, Brown G, Venuto RC.Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits[J]. Am J Med Sci, 1992, 303(4): 233-240. [58] Woods LL, Brooks VL.Role of the renin-angiotensin system in hypertension during reduced uteroplacental perfusion pressure[J]. Am J Physiol, 1989, 257(1 Pt 2):R204-209. [59] Abitbol MM.A simplified technique to produce toxemia in the pregnant dog[J]. Am J Obstet Gynecol, 1981, 139(5): 526-534. [60] Combs CA, Katz MA, Kitzmiller JL, et al.Experimental preeclampsia produced by chronic constriction of the lower aorta: validation with longitudinal blood pressure measurements in conscious rhesus monkeys[J]. Am J Obstet Gynecol, 1993, 169(1):215-223. [61] Cavanagh D, Rao PS, Tsai CC, et al.Experimental toxemia in the pregnant primate[J]. Am J Obstet Gynecol, 1977, 128(1):75-85. [62] Ke C.[Reconstruction of the urethra with a transposed pedicle skin-tube from the labium majus][J]. Zhonghua Wai Ke Za Zhi, 1983, 21(6):364. [63] Bauer AJ, Banek CT, Needham K, et al.Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension[J]. Hypertension, 2013, 61(5):1103-1110. [64] Alexander BT, Kassab SE, Miller MT, et al.Reduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxide[J]. Hypertension, 2001, 37(4):1191-1195. [65] 周晶, 严国锋, 罗章源, 等. 子痫前期大鼠模型建立及相关指标监测[J]. 实验动物与比较医学, 2015, 35(6):448-452. [66] Spradley FT, Tan AY, Joo WS, et al.Placental growth factor administration abolishes placental ischemia-induced hypertension[J]. Hypertension, 2016, 67(4):740-747. [67] Fraser GM, Morton JS, Schmidt SM, et al.Reduced uterine perfusion pressure decreases functional capillary density in skeletal muscle[J]. Am J Physiol Heart Circ Physiol, 2015, 309(12):H2002-2007. [68] 李怡琳. 合体滋养细胞微绒毛膜制备子痫前期动物模型的研究[D]. 重庆: 第三军医大学, 2013. [69] 刘晓洁. 合体滋养细胞微绒毛膜在子痫前期发病中作用的研究[D]. 重庆:第三军医大学, 2014. [70] Tal R, Shaish A, Barshack I, et al.Effects of hypoxia-inducible factor-1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction[J]. Am J Pathol, 2010, 177(6):2950-2962. [71] Haase N, Golic M, Herse F, et al.Relaxin treatment in an ang-II-based transgenic preeclamptic-rat model[J]. PLoS One, 2016, 11(3):e0150743. [72] Kanasaki K, Palmsten K, Sugimoto H, et al.Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia[J]. Nature, 2008, 453(7198): 1117-1121. [73] Stanley JL, Sulek K, Andersson IJ, et al.Sildenafil therapy normalizes the aberrant metabolomic profile in the Comt(-/-) mouse model of preeclampsia/fetal growth restriction[J]. Sci Rep, 2015, 5:18241. [74] Mao L, Zhou Q, Zhou S, et al.Roles of apolipoprotein E (ApoE) and inducible nitric oxide synthase (iNOS) in inflammation and apoptosis in preeclampsia pathogenesis and progression[J]. PLoS One, 2013, 8(3):e58168. [75] 毛路一. ApoE和iNOS敲除小鼠子痫前期动物模型的建立和胎盘功能异常的研究[D]. 上海: 复旦大学, 2011. [76] Kanayama N, Takahashi K, Matsuura T, et al.Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice[J]. Mol Hum Reprod, 2002, 8(12):1129-1135. [77] Mess A, Zaki N, Kadyrov M, et al.Caviomorph placentation as a model for trophoblast invasion[J]. Placenta, 2007, 28(11-12):1234-1238. |
[1] | 刘欣, 石少波, 张翠, 杨波, 曲川. 小鼠自体动静脉内瘘端侧吻合模型的建立与评价[J]. 实验动物与比较医学, 2023, 43(6): 595-603. |
[2] | 王丹, 张晓璐, 王妍, 傅博, 王文栋, 刘京, 张甦寅, 武怡荷, 吴德国, 杜小燕, 战大伟, 章秀林, 李长龙. Big-BALB/c小鼠亚系选育前后的抗体制备效率比较研究[J]. 实验动物与比较医学, 2023, 43(6): 612-618. |
[3] | 万颖寒, 顾也欣, 袁雨浓, 汤忞, 鲁立. FDA现代化法案2.0给疾病动物模型发展带来的启示和思考[J]. 实验动物与比较医学, 2023, 43(5): 472-481. |
[4] | 谢淑武, 沈如凌, 林金杏, 范春. 雄性不育药物研发相关实验动物模型建立和应用进展[J]. 实验动物与比较医学, 2023, 43(5): 504-511. |
[5] | 陈艳娟, 沈如凌. 模式动物疾病模型在结直肠癌医学研究中的应用进展[J]. 实验动物与比较医学, 2023, 43(5): 512-523. |
[6] | 张睿, 吕美豫, 张建军, 刘金莲, 陈彦, 黄志强, 刘尧, 周澜华. 痤疮动物模型建立及评价研究进展[J]. 实验动物与比较医学, 2023, 43(4): 398-405. |
[7] | 卢今, 王剑, 朱莲, 严国锋, 马政文, 李垚, 戴建军, 朱寅秋, 周晶. 山羊先兆子痫疾病模型的构建及母体生物学特性评价[J]. 实验动物与比较医学, 2023, 43(4): 371-380. |
[8] | 俞佳慧, 巩倩, 庄乐南. 肺动脉高压动物模型及其在药物研究中的应用进展[J]. 实验动物与比较医学, 2023, 43(4): 381-397. |
[9] | 邓亚胜, 林江, 甘池伶, 曾官凤, 黄嘉茵, 邓慧芳, 麻颖贤, 韩丝银. 皮肤光老化动物模型制备要素和受试物数据的文献分析[J]. 实验动物与比较医学, 2023, 43(4): 406-414. |
[10] | 王雪, 呼永河. 糖尿病小鼠模型的常见种类及其构建要素分析[J]. 实验动物与比较医学, 2023, 43(4): 415-421. |
[11] | 黄慧, 邓亚胜, 梁天薇, 郑艺清, 范燕萍, 荣娜, 林江. 卵巢储备功能减退动物模型的造模方法评价与分析[J]. 实验动物与比较医学, 2023, 43(4): 422-428. |
[12] | 相磊, 景金珠, 梁震, 阎国强, 郭文峰, 张萌, 张威, 刘亚军. 基于VOSviewer的肌少症动物模型研究可视化分析[J]. 实验动物与比较医学, 2023, 43(4): 429-439. |
[13] | 谭志刚, 刘锦信, 郑楚雅, 廖文峰, 冯露平, 彭红丽, 严秀, 卓振建. 神经母细胞瘤动物模型研究进展与应用[J]. 实验动物与比较医学, 2023, 43(3): 288-296. |
[14] | 赖灿, 李乐乐, 胡塔拉, 孟彦. 肾脏间质纤维化动物模型的研究进展[J]. 实验动物与比较医学, 2023, 43(2): 163-172. |
[15] | 胡玲, 胡志斌, 胡筠卿, 丁玉强. 精神分裂症动物模型的研究概述[J]. 实验动物与比较医学, 2023, 43(2): 145-155. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||